In addition, recent studies demonstrated that HER-2 specific CTLs, generated from HLA-A2 positive patients with HER-2 positive breast cancer, can lyse HER-2 positive SKOV3tA2 breast cancer cells in a HLA-A2 restricted manner [25]. Here, ERBB2 is linked to breast carcinoma.